Sequential re-rating: management describes the same offering landing bigger the second and third time around
The model's full reasoning — Q2 2017 call → NO我们根据提供的财报电话会议记录,判断管理层是否描述了“同类业务连续接单规模逐步扩大”的现象。需要寻找管理层关于订单、合同、项目、客户、站点或项目规模逐步增大的表述,并与公司自身过去进行对比,且这种扩大是已实现、正在形成或预期持续的。 在记录中,管理层提到: - FPD业务在季度内逐月改善,产能接近满载,并计划增加产能。 - 高端的IC业务,特别是逻辑芯片,在台湾疲软,但预计随着客户获得28纳米生产批准而改善。 - 关于中国合资企业,与DNP合作,旨在扩大规模,但未明确提及单个订单或项目规模增大。 - 关于FPD,提到新工具安装,预期带来收入增长,但未明确说单个订单规模增大。 - 关于高端的IC,提到14纳米、10纳米、7纳米等新节点,但未明确说单个订单规模增大。 管理层没有明确表述“现在接到的订单比过去更大”或“每个新项目规模更大”等类似内容。他们更多谈论的是需求改善、产能利用、新工具安装、市场趋势等,但没有直接对比单位规模。 因此,答案应为NO。
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| ASO | Academy Sports and Outdoors, Inc. | Q1 2024 | 2024-06-11 | C+ |
| AKYA | Akoya Biosciences, Inc. | Q2 2023 | 2023-08-07 | C+ |
| SPT | Sprout Social, Inc. | Q2 2023 | 2023-08-04 | B+ |
| SGRY | Surgery Partners, Inc. | Q2 2022 | 2022-08-02 | B+ |
| CYBR | CyberArk Software Ltd. | Q3 2021 | 2021-11-04 | B+ |
| ASAN | Asana, Inc. | Q2 2022 | 2021-09-01 | B+ |
| OWL | Blue Owl Capital Inc. | Q2 2021 | 2021-08-10 | B+ |
AKYA · Q2 2023 → YESThe question is: Does management describe that the company's SUCCESSIVE ENGAGEMENTS OF THE SAME KIND ARE COMING IN AT PROGRESSIVELY LARGER SIZE? YES The transcript shows management describing a clear pattern of escalating project sizes in the translational/clinical space. Brian notes a migration from exploratory studies (reasonable size) to larger retrospective studies and even larger retrospective-prospective ongoing clinical studies, with projects moving "further and further downstream.
ASAN · Q2 2022 → YESThe question is: Does management describe that the company's SUCCESSIVE ENGAGEMENTS OF THE SAME KIND ARE COMING IN AT PROGRESSIVELY LARGER SIZE? YES Management describes exactly this pattern. Dustin notes the company is “closing larger deals and expanding seats across departments and geographies quickly in large organizations,” and that the growth in the >$50k cohort “reflected an acceleration in our largest enterprise customers.
SGRY · Q2 2022 → YESThe question is: Does management describe that the company's SUCCESSIVE ENGAGEMENTS OF THE SAME KIND ARE COMING IN AT PROGRESSIVELY LARGER SIZE? YES The transcript shows management describing exactly this pattern for physician recruiting cohorts. Wayne notes that the 2022 cohorts are “no exception to this trend, bringing more cases with a higher overall net revenue per case than our 2021 cohorts did in the same period last year.